Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The PT-141 peptide is FDA approved as the injectable brand-name medication Vyleesi (bremelanotide), which is indicated for premenopausal women who have hypoactive sexual desire disorder not caused by a medical or mental health condition, relationship problems, or medication side effects
[PMID: 25709639] PubMed record related to this compound for laboratory literature review
These are due to finish in May 2026
High-ROS environments can degrade the peptide, which is relevant in oxidative stress model experiments
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
